These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 37020038)

  • 1. Atypical teratoid/rhabdoid tumoroids reveal subgroup-specific drug vulnerabilities.
    Paassen I; Williams J; Ríos Arceo C; Ringnalda F; Mercer KS; Buhl JL; Moreno N; Federico A; Franke NE; Kranendonk M; Upadhyaya SA; Kerl K; van de Wetering M; Clevers H; Kool M; Hoving EW; Roussel MF; Drost J
    Oncogene; 2023 May; 42(20):1661-1671. PubMed ID: 37020038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical teratoid/rhabdoid tumors (ATRTs) with SMARCA4 mutation are molecularly distinct from SMARCB1-deficient cases.
    Holdhof D; Johann PD; Spohn M; Bockmayr M; Safaei S; Joshi P; Masliah-Planchon J; Ho B; Andrianteranagna M; Bourdeaut F; Huang A; Kool M; Upadhyaya SA; Bendel AE; Indenbirken D; Foulkes WD; Bush JW; Creytens D; Kordes U; Frühwald MC; Hasselblatt M; Schüller U
    Acta Neuropathol; 2021 Feb; 141(2):291-301. PubMed ID: 33331994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sellar Region Atypical Teratoid/Rhabdoid Tumors (ATRT) in Adults Display DNA Methylation Profiles of the ATRT-MYC Subgroup.
    Johann PD; Bens S; Oyen F; Wagener R; Giannini C; Perry A; Raisanen JM; Reis GF; Nobusawa S; Arita K; Felsberg J; Reifenberger G; Agaimy A; Buslei R; Capper D; Pfister SM; Schneppenheim R; Siebert R; Frühwald MC; Paulus W; Kool M; Hasselblatt M
    Am J Surg Pathol; 2018 Apr; 42(4):506-511. PubMed ID: 29324471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional relevance of genes predicted to be affected by epigenetic alterations in atypical teratoid/rhabdoid tumors.
    Tegeder I; Thiel K; Erkek S; Johann PD; Berlandi J; Thatikonda V; Frühwald MC; Kool M; Jeibmann A; Hasselblatt M
    J Neurooncol; 2019 Jan; 141(1):43-55. PubMed ID: 30446899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A kinome drug screen identifies multi-TKI synergies and ERBB2 signaling as a therapeutic vulnerability in MYC/TYR subgroup atypical teratoid rhabdoid tumors.
    Golbourn B; Ho B; Bondoc A; Luck A; Fan X; Richardson E; Marcellus R; Prakesch M; Halbert M; Agrawal N; Smith C; Huang A; Rutka JT
    Neuro Oncol; 2024 Oct; 26(10):1895-1911. PubMed ID: 38981018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cribriform neuroepithelial tumor: molecular characterization of a SMARCB1-deficient non-rhabdoid tumor with favorable long-term outcome.
    Johann PD; Hovestadt V; Thomas C; Jeibmann A; Heß K; Bens S; Oyen F; Hawkins C; Pierson CR; Aldape K; Kim SP; Widing E; Sumerauer D; Hauser P; van Landeghem F; Ryzhova M; Korshunov A; Capper D; Jones DTW; Pfister SM; Schneppenheim R; Siebert R; Paulus W; Frühwald MC; Kool M; Hasselblatt M
    Brain Pathol; 2017 Jul; 27(4):411-418. PubMed ID: 27380723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATRT-SHH comprises three molecular subgroups with characteristic clinical and histopathological features and prognostic significance.
    Federico A; Thomas C; Miskiewicz K; Woltering N; Zin F; Nemes K; Bison B; Johann PD; Hawes D; Bens S; Kordes U; Albrecht S; Dohmen H; Hauser P; Keyvani K; van Landeghem FKH; Lund EL; Scheie D; Mawrin C; Monoranu CM; Parm Ulhøi B; Pietsch T; Reinhard H; Riemenschneider MJ; Sehested A; Sumerauer D; Siebert R; Paulus W; Frühwald MC; Kool M; Hasselblatt M
    Acta Neuropathol; 2022 Jun; 143(6):697-711. PubMed ID: 35501487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular analyses reveal close similarities between small cell carcinoma of the ovary, hypercalcemic type and atypical teratoid/rhabdoid tumor.
    Fahiminiya S; Witkowski L; Nadaf J; Carrot-Zhang J; Goudie C; Hasselblatt M; Johann P; Kool M; Lee RS; Gayden T; Roberts CW; Biegel JA; Jabado N; Majewski J; Foulkes WD
    Oncotarget; 2016 Jan; 7(2):1732-40. PubMed ID: 26646792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of MYC attenuates tumor cell self-renewal and promotes senescence in SMARCB1-deficient Group 2 atypical teratoid rhabdoid tumors to suppress tumor growth in vivo.
    Alimova I; Pierce A; Danis E; Donson A; Birks DK; Griesinger A; Foreman NK; Santi M; Soucek L; Venkataraman S; Vibhakar R
    Int J Cancer; 2019 Apr; 144(8):1983-1995. PubMed ID: 30230537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid Tumors.
    Torchia J; Golbourn B; Feng S; Ho KC; Sin-Chan P; Vasiljevic A; Norman JD; Guilhamon P; Garzia L; Agamez NR; Lu M; Chan TS; Picard D; de Antonellis P; Khuong-Quang DA; Planello AC; Zeller C; Barsyte-Lovejoy D; Lafay-Cousin L; Letourneau L; Bourgey M; Yu M; Gendoo DMA; Dzamba M; Barszczyk M; Medina T; Riemenschneider AN; Morrissy AS; Ra YS; Ramaswamy V; Remke M; Dunham CP; Yip S; Ng HK; Lu JQ; Mehta V; Albrecht S; Pimentel J; Chan JA; Somers GR; Faria CC; Roque L; Fouladi M; Hoffman LM; Moore AS; Wang Y; Choi SA; Hansford JR; Catchpoole D; Birks DK; Foreman NK; Strother D; Klekner A; Bognár L; Garami M; Hauser P; Hortobágyi T; Wilson B; Hukin J; Carret AS; Van Meter TE; Hwang EI; Gajjar A; Chiou SH; Nakamura H; Toledano H; Fried I; Fults D; Wataya T; Fryer C; Eisenstat DD; Scheinemann K; Fleming AJ; Johnston DL; Michaud J; Zelcer S; Hammond R; Afzal S; Ramsay DA; Sirachainan N; Hongeng S; Larbcharoensub N; Grundy RG; Lulla RR; Fangusaro JR; Druker H; Bartels U; Grant R; Malkin D; McGlade CJ; Nicolaides T; Tihan T; Phillips J; Majewski J; Montpetit A; Bourque G; Bader GD; Reddy AT; Gillespie GY; Warmuth-Metz M; Rutkowski S; Tabori U; Lupien M; Brudno M; Schüller U; Pietsch T; Judkins AR; Hawkins CE; Bouffet E; Kim SK; Dirks PB; Taylor MD; Erdreich-Epstein A; Arrowsmith CH; De Carvalho DD; Rutka JT; Jabado N; Huang A
    Cancer Cell; 2016 Dec; 30(6):891-908. PubMed ID: 27960086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal cord atypical teratoid/rhabdoid tumors in children: Clinical, genetic, and outcome characteristics in a representative European cohort.
    Benesch M; Nemes K; Neumayer P; Hasselblatt M; Timmermann B; Bison B; Ebetsberger-Dachs G; Bourdeaut F; Dufour C; Biassoni V; Morales La Madrid A; Entz-Werle N; Laithier V; Quehenberger F; Weis S; Sumerauer D; Siebert R; Bens S; Schneppenheim R; Kool M; Modena P; Fouyssac F; C Frühwald M
    Pediatr Blood Cancer; 2020 Jan; 67(1):e28022. PubMed ID: 31571386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular subgrouping of atypical teratoid/rhabdoid tumors-a reinvestigation and current consensus.
    Ho B; Johann PD; Grabovska Y; De Dieu Andrianteranagna MJ; Yao F; Frühwald M; Hasselblatt M; Bourdeaut F; Williamson D; Huang A; Kool M
    Neuro Oncol; 2020 May; 22(5):613-624. PubMed ID: 31889194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SMARCB1 Gene Therapy Using a Novel Tumor-Targeted Nanomedicine Enhances Anti-Cancer Efficacy in a Mouse Model of Atypical Teratoid Rhabdoid Tumors.
    Kim SS; Moghe M; Rait A; Donaldson K; Harford JB; Chang EH
    Int J Nanomedicine; 2024; 19():5973-5993. PubMed ID: 38895149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age and DNA methylation subgroup as potential independent risk factors for treatment stratification in children with atypical teratoid/rhabdoid tumors.
    Frühwald MC; Hasselblatt M; Nemes K; Bens S; Steinbügl M; Johann PD; Kerl K; Hauser P; Quiroga E; Solano-Paez P; Biassoni V; Gil-da-Costa MJ; Perek-Polnik M; van de Wetering M; Sumerauer D; Pears J; Stabell N; Holm S; Hengartner H; Gerber NU; Grotzer M; Boos J; Ebinger M; Tippelt S; Paulus W; Furtwängler R; Hernáiz-Driever P; Reinhard H; Rutkowski S; Schlegel PG; Schmid I; Kortmann RD; Timmermann B; Warmuth-Metz M; Kordes U; Gerss J; Nysom K; Schneppenheim R; Siebert R; Kool M; Graf N
    Neuro Oncol; 2020 Jul; 22(7):1006-1017. PubMed ID: 31883020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advancing biology-based therapeutic approaches for atypical teratoid rhabdoid tumors.
    Hoffman LM; Richardson EA; Ho B; Margol A; Reddy A; Lafay-Cousin L; Chi S; Slavc I; Judkins A; Hasselblatt M; Bourdeaut F; Frühwald MC; Vibhakar R; Bouffet E; Huang A
    Neuro Oncol; 2020 Jul; 22(7):944-954. PubMed ID: 32129445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical Teratoid/Rhabdoid Tumors Are Comprised of Three Epigenetic Subgroups with Distinct Enhancer Landscapes.
    Johann PD; Erkek S; Zapatka M; Kerl K; Buchhalter I; Hovestadt V; Jones DTW; Sturm D; Hermann C; Segura Wang M; Korshunov A; Rhyzova M; Gröbner S; Brabetz S; Chavez L; Bens S; Gröschel S; Kratochwil F; Wittmann A; Sieber L; Geörg C; Wolf S; Beck K; Oyen F; Capper D; van Sluis P; Volckmann R; Koster J; Versteeg R; von Deimling A; Milde T; Witt O; Kulozik AE; Ebinger M; Shalaby T; Grotzer M; Sumerauer D; Zamecnik J; Mora J; Jabado N; Taylor MD; Huang A; Aronica E; Bertoni A; Radlwimmer B; Pietsch T; Schüller U; Schneppenheim R; Northcott PA; Korbel JO; Siebert R; Frühwald MC; Lichter P; Eils R; Gajjar A; Hasselblatt M; Pfister SM; Kool M
    Cancer Cell; 2016 Mar; 29(3):379-393. PubMed ID: 26923874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging and multi-omics datasets converge to define different neural progenitor origins for ATRT-SHH subgroups.
    Lobón-Iglesias MJ; Andrianteranagna M; Han ZY; Chauvin C; Masliah-Planchon J; Manriquez V; Tauziede-Espariat A; Turczynski S; Bouarich-Bourimi R; Frah M; Dufour C; Blauwblomme T; Cardoen L; Pierron G; Maillot L; Guillemot D; Reynaud S; Bourneix C; Pouponnot C; Surdez D; Bohec M; Baulande S; Delattre O; Piaggio E; Ayrault O; Waterfall JJ; Servant N; Beccaria K; Dangouloff-Ros V; Bourdeaut F
    Nat Commun; 2023 Oct; 14(1):6669. PubMed ID: 37863903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SMARCB1 loss induces druggable cyclin D1 deficiency via upregulation of MIR17HG in atypical teratoid rhabdoid tumors.
    Xue Y; Zhu X; Meehan B; Venneti S; Martinez D; Morin G; Maïga RI; Chen H; Papadakis AI; Johnson RM; O'Sullivan MJ; Erdreich-Epstein A; Gotlieb WH; Park M; Judkins AR; Pelletier J; Foulkes WD; Rak J; Huang S
    J Pathol; 2020 Sep; 252(1):77-87. PubMed ID: 32558936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SMAD dependent signaling plays a detrimental role in a fly model of SMARCB1-deficiency and the biology of atypical teratoid/rhabdoid tumors.
    Jeibmann A; Schulz J; Eikmeier K; Johann PD; Thiel K; Tegeder I; Ambrée O; Frühwald MC; Pfister SM; Kool M; Paulus W; Hasselblatt M
    J Neurooncol; 2017 Feb; 131(3):477-484. PubMed ID: 28108836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of nuclear export restores nuclear localization and residual tumor suppressor function of truncated SMARCB1/INI1 protein in a molecular subset of atypical teratoid/rhabdoid tumors.
    Pathak R; Zin F; Thomas C; Bens S; Gayden T; Karamchandani J; Dudley RW; Nemes K; Johann PD; Oyen F; Kordes U; Jabado N; Siebert R; Paulus W; Kool M; Frühwald MC; Albrecht S; Kalpana GV; Hasselblatt M
    Acta Neuropathol; 2021 Aug; 142(2):361-374. PubMed ID: 34003336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.